Skip to content

Black Bird Biotech, Inc.: 10-Q filed 2012-11-13

What Black Bird Biotech, Inc. reported in its quarterly report filed 2012-11-13 (fiscal Q3 2012): 17 published measures, 49 facts as tagged in accession 0001354488-12-005760.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-13
Fiscal period
fiscal Q3 2012
Accession
0001354488-12-005760 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Black Bird Biotech, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-3015,776USD
At 2011-12-3149,831USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-30368,049USD
At 2011-12-31342,772USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-30-352,273USD
At 2011-12-31-292,941USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-3015,776USD
At 2011-12-3149,831USD
At 2011-09-3048,408USD
At 2010-12-31196,676USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-24,093USD92
2012-01-01 to 2012-09-30-59,332USD274
2011-07-01 to 2011-09-30-17,624USD92
2011-01-01 to 2011-09-30-119,731USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-54,055USD274
2011-01-01 to 2011-09-30148,398USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274
2011-07-01 to 2011-09-30195,002USD92
2011-01-01 to 2011-09-301,116,887USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-3020,000USD274
2011-01-01 to 2011-09-30-301,666USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-20,209USD92
2012-01-01 to 2012-09-30-48,074USD274
2011-07-01 to 2011-09-30-13,873USD92
2011-01-01 to 2011-09-30-107,708USD273

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-303,885USD92
2012-01-01 to 2012-09-3011,263USD274
2011-07-01 to 2011-09-303,751USD92
2011-01-01 to 2011-09-3012,023USD273

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-3048,049USD
At 2011-12-3142,772USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274
2011-07-01 to 2011-09-3015,002USD92
2011-01-01 to 2011-09-3082,897USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3086,402,665shares
At 2011-12-3186,402,665shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2012-09-308,281,164USD
At 2011-12-318,281,164USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2012-09-302,639,700USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-3020,209USD92
2012-01-01 to 2012-09-3048,074USD274
2011-07-01 to 2011-09-3028,875USD92
2011-01-01 to 2011-09-30190,605USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-3,884USD92
2012-01-01 to 2012-09-30-11,258USD274
2011-07-01 to 2011-09-30-3,751USD92
2011-01-01 to 2011-09-30-12,023USD273

Inspect the source

Entity
Black Bird Biotech, Inc. / CIK 0001409999
Captured
SEC response SHA-256
df936db10ff162447a769152b36bd1ddff9f21ac96d53dd4e87253b660581055

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001409999.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))